September 2022

Merck owns U.S. Patent 7,326,708, which describes sitagliptin dihydrogenphosphate, a dipeptidyl peptidase-IV (“DP-IV”) inhibitor, which can be used for treating non-insulin-dependent (i.e., Type 2) diabetes. Mylan petitioned for inter partes…

Cooperative sued Kollective for infringement of U.S. Patent No. 9,432,452 relating to systems and methods of structuring a peer-to-peer (P2P) dynamic network for distributing large files, namely videos and video…

Weber petitioned for inter partes review (“IPR”) of claims 1–14 of Provisur’s U.S. Patent No. 6,997,089 relating to methods and systems for classifying slices of a food product using an…

Polaris filed a complaint accusing NVIDIA of infringing certain claims of U.S. Patent Nos. 6,532,505 and  7,405,993, and NVIDIA responded by filing IPR petitions challenging certain claims in those patents.…

Sawstop appeals the District Court’s denial of its challenge to the PTO’s interpretation of  35 U.S.C. § 154(b)(1)(C)(iii) and the denial of Sawstop’s requests for adjustment to the term of U.S.…

Hyatt filed U.S. Patent Application No. 08/435,938, which claims priority to applications filed as early as 1983, during the GATT Bubble (i.e., it was a transitional application filed but not…

Arendi sued LG alleging that various LG products infringed U.S. Patent No. 7,917,843. The local discovery rules required Arendi to specifically identify the accused products and the asserted patent(s) they…